Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Nobel Laureate, Professor of Biology, Caltech
CEO of Dynamis Corporation
This symposium will cover new technologies being used to profile the causes of human disease, including advances in quantitative proteomics, clinical screening data, and new biotech developments that may make personalized medicine a reality. Speakers include Charles Cantor of Sequenom and Mark Ladanyi of Memorial Sloan-Kettering Cancer Center. Register here.